Viral Vectors & Plasmid DNA Manufacturing Market Dynamics, Forecast, Analysis and Supply Demand 2017–2025
The gene therapy arena has gained significant momentum from the last decade in research areas such as cancer treatment, vaccination, rare genetic diseases, etc. The most common vector being used in these gene modification studies include viruses and plasmid DNAs. Gene modification therapies very rarely receive regulatory approval; however, the viral vectors and plasmid DNAs are extensively used for preclinical and clinical trials. These vectors which are used for commercial trials are manufactured using cGMP guidelines, and are highly documented...
View full press release